197 related articles for article (PubMed ID: 10573079)
21. Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival.
Lin H; Wei RQ; Bolling SF
J Surg Res; 1993 Oct; 55(4):441-5. PubMed ID: 8412131
[TBL] [Abstract][Full Text] [Related]
22. Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation.
Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Nagasawa H; Himeno K
Transplantation; 1998 Jan; 65(1):27-32. PubMed ID: 9448139
[TBL] [Abstract][Full Text] [Related]
23. Durability of donor-specific and organ-specific heart transplant tolerance induced by intrathymic pretreatment with allogeneic spleen cells.
Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):429-31. PubMed ID: 8583817
[TBL] [Abstract][Full Text] [Related]
24. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
[TBL] [Abstract][Full Text] [Related]
25. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
26. Prolongation of renal allograft survival in the rat treated with amniotic fluid.
Yoshimura N; Matsui S; Hamashima T; Lee CJ; Ohsaka Y; Hirakawa K; Oka T
Transplantation; 1991 Sep; 52(3):540-5. PubMed ID: 1716799
[TBL] [Abstract][Full Text] [Related]
27. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
Boyle MJ; Dumble LJ
Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
[TBL] [Abstract][Full Text] [Related]
28. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
29. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig.
Guillot C; Ménoret S; Guillonneau C; Braudeau C; Castro MG; Lowenstein P; Anegon I
Blood; 2003 Apr; 101(8):3325-33. PubMed ID: 12515725
[TBL] [Abstract][Full Text] [Related]
30. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
Shirwan H; Barwari L; Khan NS
Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
[TBL] [Abstract][Full Text] [Related]
31. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
Qin L; Ding Y; Tahara H; Bromberg JS
J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
[TBL] [Abstract][Full Text] [Related]
32. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
33. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
34. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
[TBL] [Abstract][Full Text] [Related]
35. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
36. Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination.
Zavazava N; Fändrich F; Zhu X; Freese A; Behrens D; Yoo-Ott KA
J Leukoc Biol; 2000 Jun; 67(6):793-800. PubMed ID: 10857851
[TBL] [Abstract][Full Text] [Related]
37. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
Levy AE; Alexander JW; Babcock GF
Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
39. Promotion of rat cardiac allograft survival by intrathymic inoculation of donor splenocytes.
Odorico JS; Posselt AM; Naji A; Markmann JF; Barker CF
Transplantation; 1993 May; 55(5):1104-7. PubMed ID: 8497889
[TBL] [Abstract][Full Text] [Related]
40. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
